A Patient With Tricyclic Antidepressant Overdose With Catecholamine-Resistant Hypotension Rescued With Angiotensin...

Area of Science:

• Pharmacology
• Critical Care Medicine
• Toxicology

Background:

• Tricyclic antidepressant (TCA) overdose can cause life-threatening vasodilatory shock.
• Standard management of vasodilatory shock includes catecholamine vasopressors.
• Novel therapeutic strategies are needed to address refractory hypotension in TCA overdose.

Observation:

• A patient with severe vasodilatory shock due to tricyclic overdose presented with refractory hypotension.
• Angiotensin II (Giapreza) was administered to augment blood pressure.
• Hemodynamic parameters were closely monitored following angiotensin II administration.

Findings:

• Angiotensin II administration led to significant improvement in hemodynamic parameters, including mean arterial pressure.
• The successful use of angiotensin II allowed for a dose reduction of concurrent catecholamine vasopressors.
• This intervention effectively managed the vasodilatory shock in the context of tricyclic toxicity.

Implications:

• Angiotensin II represents a potential novel therapeutic option for managing vasodilatory shock, particularly in drug-induced cases like tricyclic overdose.
• Its use may offer an alternative or adjunctive therapy to traditional vasopressors, potentially improving patient outcomes.
• Further research is warranted to establish the efficacy and safety profile of angiotensin II in similar clinical scenarios.